Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp > come to thinj of it

<< Previous

Bullboard Posts

Next >>

Comment by WakeUPPon Sep 13, 2021 3:51pm

98 Views

Post# 33849968

RE:RE:RE:come to thinj of it

oooooooooooooooh

you own it for a deal with a pharma co

they have a dealwith beer, market cap 14million on the way to zero

who do they have a deal with for pharma?

NO ONE

who is gonna do a deal with a comoany tHAT has postive result on 10 rats?

NO ONE

<< Previous

Bullboard Posts

Next >>

Boeing workers end strike, return to work